Saturday, July 11, 2026

biotech

Dragonboat Biopharmaceutical Company

Dragonboat Biopharmaceutical Company is a biotech organization headquartered in CN. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrial

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
3
Patents
0
Clinical program

anti-EGFR monoclonal antibody

Phase 1 · small molecule · Healthy Volunteers

anti-EGFR monoclonal antibody for Healthy Volunteers is a Phase 1 program (small_molecule) at Dragonboat Biopharmaceutical Company Limited with 1 ClinicalTrials.gov record(s).

Internal code CDP100002

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Dragonboat Biopharmaceutical Company Limited
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Volunteers
Status
active
Trials
1